Úrsula Muñoz

975 total citations
41 papers, 691 citations indexed

About

Úrsula Muñoz is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Úrsula Muñoz has authored 41 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Physiology. Recurrent topics in Úrsula Muñoz's work include Growth Hormone and Insulin-like Growth Factors (9 papers), Alzheimer's disease research and treatments (6 papers) and Health and Medical Education (5 papers). Úrsula Muñoz is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (9 papers), Alzheimer's disease research and treatments (6 papers) and Health and Medical Education (5 papers). Úrsula Muñoz collaborates with scholars based in Spain, Mexico and United States. Úrsula Muñoz's co-authors include Ángeles Martín‐Requero, Fernando Benito Bartolomé, Juan Enrique Puche, Scott L. Friedman, Inma Castilla‐Cortázar, Fẽlix Bermejo, María C. Sádaba, Gabriel A. Aguirre, Ursula E. Lang and Noemí Esteras and has published in prestigious journals such as PLoS ONE, Hepatology and Oncogene.

In The Last Decade

Úrsula Muñoz

40 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Úrsula Muñoz Spain 16 283 157 107 86 79 41 691
Shohei Sakamoto Japan 14 187 0.7× 90 0.6× 147 1.4× 42 0.5× 31 0.4× 23 588
Fabrice Jaffré France 11 429 1.5× 64 0.4× 101 0.9× 68 0.8× 35 0.4× 17 831
Toni Segovia‐Silvestre Denmark 14 335 1.2× 97 0.6× 66 0.6× 49 0.6× 82 1.0× 20 759
Marcus Alvarez United States 12 352 1.2× 130 0.8× 144 1.3× 26 0.3× 137 1.7× 25 659
Antony Kaspi Australia 17 820 2.9× 127 0.8× 159 1.5× 94 1.1× 171 2.2× 29 1.3k
Tatsuro Takino Japan 16 210 0.7× 96 0.6× 154 1.4× 148 1.7× 82 1.0× 94 923
Uta Lichter‐Konecki United States 20 608 2.1× 223 1.4× 59 0.6× 39 0.5× 30 0.4× 35 1.1k
Zhiyu Yang Australia 17 286 1.0× 43 0.3× 84 0.8× 34 0.4× 98 1.2× 41 701
Zong Miao China 17 631 2.2× 130 0.8× 173 1.6× 17 0.2× 261 3.3× 29 1.1k
Gábor Nagy Hungary 12 574 2.0× 79 0.5× 85 0.8× 32 0.4× 43 0.5× 19 876

Countries citing papers authored by Úrsula Muñoz

Since Specialization
Citations

This map shows the geographic impact of Úrsula Muñoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Úrsula Muñoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Úrsula Muñoz more than expected).

Fields of papers citing papers by Úrsula Muñoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Úrsula Muñoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Úrsula Muñoz. The network helps show where Úrsula Muñoz may publish in the future.

Co-authorship network of co-authors of Úrsula Muñoz

This figure shows the co-authorship network connecting the top 25 collaborators of Úrsula Muñoz. A scholar is included among the top collaborators of Úrsula Muñoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Úrsula Muñoz. Úrsula Muñoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gradillas, Ana, Alma Villaseñor, Vanesa Alonso‐Herranz, et al.. (2023). Deficiency in the production of antibodies to lipids correlates with increased lipid metabolism in severe COVID-19 patients. Frontiers in Immunology. 14. 1188786–1188786. 7 indexed citations
2.
Tutor, Antonio S., Esther Escudero, Juan Aranda, et al.. (2023). Learning and assessment strategies to develop specific and transversal competencies for a humanized medical education. Frontiers in Physiology. 14. 1212031–1212031. 4 indexed citations
3.
Muñoz, Úrsula, Esther Escudero, Margaret M. Esiri, et al.. (2021). Main Role of Antibodies in Demyelination and Axonal Damage in Multiple Sclerosis. Cellular and Molecular Neurobiology. 42(6). 1809–1827. 20 indexed citations
4.
Sádaba, María C., Veit Rothhammer, Úrsula Muñoz, et al.. (2020). Serum antibodies to phosphatidylcholine in MS. Neurology Neuroimmunology & Neuroinflammation. 7(4). 17 indexed citations
5.
Castilla‐Cortázar, Inma, Gabriel A. Aguirre, Úrsula Muñoz, et al.. (2017). Partial IGF-1 deficiency is sufficient to reduce heart contractibility, angiotensin II sensibility, and alter gene expression of structural and functional cardiac proteins. PLoS ONE. 12(8). e0181760–e0181760. 19 indexed citations
6.
Morales-Garza, Luis Alonso, Juan Enrique Puche, Gabriel A. Aguirre, et al.. (2017). Experimental approach to IGF-1 therapy in CCl4-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency. Journal of Translational Medicine. 15(1). 96–96. 10 indexed citations
7.
Díaz, Víctor J., et al.. (2017). IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture. Journal of Physiology and Biochemistry. 73(2). 245–258. 34 indexed citations
8.
Castilla‐Cortázar, Inma, A. M. Gago, Úrsula Muñoz, et al.. (2015). Mechanisms Underlying Testicular Damage and Dysfunction in Mice With Partial IGF-1 Deficiency and the Effectiveness of IGF-1 Replacement Therapy. Urology. 86(6). 1241.e1–1241.e9. 14 indexed citations
9.
Castilla‐Cortázar, Inma, et al.. (2013). An experimental model of partial insulin-like growth factor-1 deficiency in mice. Journal of Physiology and Biochemistry. 70(1). 129–139. 20 indexed citations
10.
Puche, Juan Enrique, Youngmin A. Lee, Costica Aloman, et al.. (2012). A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice. Hepatology. 57(1). 339–350. 109 indexed citations
11.
Lang, Ursula E., Peri Kocabayoglu, George Z. Cheng, et al.. (2012). GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21. Oncogene. 32(38). 4557–4564. 36 indexed citations
12.
Esteras, Noemí, Úrsula Muñoz, Carolina Alquézar, et al.. (2012). Altered Calmodulin Degradation and Signaling in Non-Neuronal Cells from Alzheimer’s Disease Patients. Current Alzheimer Research. 9(3). 267–277. 18 indexed citations
13.
Bechmann, Lars P., Diana Vetter, Rebekka A. Hannivoort, et al.. (2011). 94 KRÜPPEL-LIKE FACTOR 6 REGULATES PPAR ALPHA SIGNALING IN STEATOHEPATITIS VIA REPRESSION OF MIR-10B. Journal of Hepatology. 54. S42–S42. 1 indexed citations
14.
Muñoz, Úrsula, et al.. (2010). Cell cycle and Alzheimer's disease: studies in non-neuronal cells. Journal of Applied Biomedicine. 8(3). 121–130. 9 indexed citations
15.
Bartolomé, Fernando Benito, Úrsula Muñoz, Noemí Esteras, et al.. (2010). Simvastatin overcomes the resistance to serum withdrawal-induced apoptosis of lymphocytes from Alzheimer’s disease patients. Cellular and Molecular Life Sciences. 67(24). 4257–4268. 11 indexed citations
16.
Muñoz, Úrsula, Fernando Benito Bartolomé, Noemí Esteras, Félix Bermejo‐Pareja, & Ángeles Martín‐Requero. (2008). On the mechanism of inhibition of p27 degradation by 15-deoxy-Δ12,14-prostaglandin J 2 in lymphoblasts of Alzheimer’s disease patients. Cellular and Molecular Life Sciences. 65(21). 3507–3519. 8 indexed citations
17.
Muñoz, Úrsula, Fernando Benito Bartolomé, Fẽlix Bermejo, & Ángeles Martín‐Requero. (2007). Enhanced proteasome-dependent degradation of the CDK inhibitor p27kip1 in immortalized lymphocytes from Alzheimer's dementia patients. Neurobiology of Aging. 29(10). 1474–1484. 42 indexed citations
18.
19.
20.
Muñoz, Úrsula, et al.. (2004). Altered transcriptional regulators in response to serum in immortalized lymphocytes from Alzheimer's disease patients. Neurobiology of Aging. 26(5). 615–624. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shohei Sakamoto Breakdown of academic impact, for papers by Fabrice Jaffré Breakdown of academic impact, for papers by Toni Segovia‐Silvestre Breakdown of academic impact, for papers by Marcus Alvarez Breakdown of academic impact, for papers by Antony Kaspi Breakdown of academic impact, for papers by Tatsuro Takino Breakdown of academic impact, for papers by Uta Lichter‐Konecki Breakdown of academic impact, for papers by Zhiyu Yang Breakdown of academic impact, for papers by Zong Miao Breakdown of academic impact, for papers by Gábor Nagy
Rankless by CCL
2026